Not sure of the message here. FDA has not approved anything for CYDY. Venturing into COVID was the correct play at the time. Experienced Pharma executives did not believe M2M could be monetized (and it can’t) based on yesterday’s call, which is why as NP says “ no one else was testing for M2M”. Other more experienced executives apparently knew better. FDA told CYDY to stop doing Emergency treatments and focus on a real studies, which is when CYCY launched the real studies. FDA had to TELL CYDY to do a proper study for COVID; FDA did not approve anything, they told us to clinically prove it.
News 
Market Data 
Discover 
AI
